Pfizer
UK becomes first country to approve Pfizer-BioNTech Covid vaccine
The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, paving the way for mass vaccinations against the deadly novel coronavirus. The British regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), says the jab, which claims to offer up to 95 per cent protection against COVID-19 illness, is safe […]
4 years ago#Northeast Live Digital Desk
Pfizer says COVID-19 vaccine 95% effective in final trials with no safety concerns
American drug giant Pfizer on Wednesday said that final results from the late-stage trial of its coronavirus vaccine was found to be 95 per cent effective and had no serious side effects on older people. The findings are based on two doses given to more than 41,000 people around the world, said the US drugmaker […]
4 years ago#Northeast Live Digital Desk
Keeping Pfizer’s COVID-19 vaccine at low temperatures will be challenging for India: AIIMS Director
Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer’s COVID-19 vaccine phase III trials are very encouraging but preserving it at very low temperatures, -70 degree C, will be a challenge for India and other nations, especially in rural areas. Speaking to ANI, Guleria […]
4 years ago#Northeast Live Digital Desk
Pfizer says its coronavirus vaccine more than 90 pc effective in first analysis
The coronavirus vaccine developed by drug giant American Pfizer and German biotechnology firm BioNTech was more than 90 per cent effective at protecting people from infection as compared to placebo saline shot, according to an analysis. The analysis was conducted by an independent data monitoring committee that met Sunday. “I would say it is a […]
4 years ago